Saturday, 14 December 2019

India News

  • Philips opens manufacturing facility in India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

    Bangalore: In line with its strategy to expand the company's industrial footprint in India, Royal Philips Electronics commenced operations at its first greenfield manufacturing facility for...Read more

  • IPDA wants export ban on medicines lifted

    India |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2014

    Singapore: The Maharashtra Food and Drug Administration (FDA) in India has enforced a ban on export of pharma products through parcel posts in February this year. Pharma companies in Mahara...Read more

  • Cadila chairman Indravadan Modi passes away

    India |  News | By BioSpectrum Bureau  | 0 Comment | 27 Nov, 2012

    Bangalore: Veteran industrialist and one of pioneers of Indian pharmaceuticals industry Mr Indravadan Modi, the chairman of Cadila Pharmaceuticals and group companies, passed away on Novemb...Read more

  • First-of-its-kind osteoarthritis study done in India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

    Bangalore: Signaling relief to over 15 million knee-osteoarthritis patients in India, the world's first study "Osteoarthritis Synvisc One Indian Post Marketing Study" (OASIS) has revealed ...Read more

  • India to introduce new medical device Bill

    India |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Jun, 2013

    Singapore: The Indian government will soon bring a Bill aimed at regulating the medical equipment industry in the county, which so far has remained unregulated. The new Bill will replace th...Read more

  • Panacea gets govt order worth $34 million

    India |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2012

    New Delhi: India's second largest producer of vaccines, New Delhi-based Panacea Biotec, has received a government order worth $34 million (Rs 187.61 crore) for the supply of 345 million dos...Read more

  • Indian FIPB clears pharma FDI proposals worth $536 mn

    India |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

    New Delhi: The Indian Foreign Investment Promotion Board (FIPB), which is the foreign investment approval authority, has cleared eight of the ten pending proposals of foreign drug firms tha...Read more

  • WHO: Invest in local research to improve healthcare

    India |  News | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2013

    Singapore: WHO has urged countries to invest in local research in order to develop a system of universal health coverage tailored to each individual country's situation to help ensure that ...Read more

  • Arvind sets up $42.37 mn plant top tap US market

    India |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company has invested $42.37 million to set up a new manufacturing facility at ...Read more

  • BioEnable launch biometric kiosks

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Bangalore: BioEnable Technologies announced the launch of their new generation Biometric Kiosks. The device type is used for a number of different applications including food coupons, self...Read more

  • What are India's most eminent life science individuals saying about CSIR?

    India |  Analysis | By Rahul Koul Koul | 0 Comment | 21 Nov, 2012

    India's Council of Scientific and Industrial Research (CSIR), which was established in 1942 as an autonomous society and with 37 state-of-the-art institutes by Dr Shanti Swarup Bhatnagar, h...Read more

  • Ranbaxy, Gilead sign licensing agreement

    India |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

    New Delhi: Ranbaxy Laboratories has entered into an in-licensing agreement with Gilead Sciences to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtrici...Read more

  • NSF brings Secondary Reference Standards to India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: NSF International, an independent global public health and safety organization which develops standards, and tests and certifies products for the pharmaceutical, dietary suppleme...Read more

  • Abuse of clinical trial laws need to be prevented

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 15 Oct, 2012

    Clinical trial is a process which involves testing of efficacy of drugs for the purpose of determination of safety, proper dosage range and side effects, prior to the drug being certified a...Read more

  • QIAGEN gets SFDA's nod for careHPV Test

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: QIAGEN announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test and instrument platform. The careHPV Test is the first molecular diagn...Read more

  • GlobalData: Osteoporosis market to be $8 bn

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the UK, Japan, China, and India will reach a value of $8 billion in 2022 ...Read more

  • Cipla gets drug pricing breather from Delhi Court

    India |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not to take coercive steps against pharma major Cipla. The company was tol...Read more

  • Industry body expresses concern over Nexavar decision

    India |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2012

    The Association of Biotechnology Led Enterprises (ABLE), a national forum that represents the $4 billion biotechnology industry in India, reacted sharply to India's grant of a compulsory li...Read more



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls